Neudle.com: "dopamine blocking agent"

Differential
(Click to cross reference)

acetaminophen

acetylcholine

acquired immunodeficiency syndrome

acrochordon

acromegaly

advances in neurology

adverse drug reaction

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, Parkinson-dementia-complex

analgesic

anatomy of

antibiotics

anticholinergic drugs

anticonvulsants

anticonvulsants, untoward effects of

attention deficit disorder with hyperactivity

atypical

autonomic dysfunction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

carbon monoxide poisoning

carpal tunnel syndrome

caspases

CAT scan, abnormal

catatonia

cerebellar pontine angle

cerebellar pontine angle tumor

cerebral infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebrovascular accident

controversies in neurology

conversion reaction

coprolalia

cost effectiveness

creatine phosphokinase(CPK)elevated

degenerative diseases of CNS

dementia

dementia, cerebrovascular disease causing

dementia, prevention of

depression

DHE

diabetes mellitus

differential diagnosis

dopamine antagonist, peripheral

dopamine depleting agents

dopamine receptor, D2

dopaminergic neurons

droperidol

drug induced neurologic disorders

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia

dystonia, drug induced

dystonia, treatment of

dystonic reaction, acute

emergencies, neurologic

emergency room

encephalitis

encephalitis, Japanese

epidemiology of neurology

eye movement, disorders of

Fahr disease

fever

flavivirus

Gilles de la Tourette syndrome

headache, evaluation of

headache, prophylaxis

headache, treatment of

hearing loss

hemiballismus

hepatolenticular degeneration(Wilson's disease)

highly active antiretroviral therapy

human immunodeficiency virus type 1

hypoxic encephalopathy

iatrogenic neurologic disorders

impotence

impulsivity

iron, brain

Jakob-Creutzfeldt disease

L-dopa

L-dopa, drug interactions with and side effects of

Leigh's disease

leukocytosis

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

lithium

liver disease

lumbar puncture, indications for

migraine, prophylaxis

migraine, treatment of

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, post hemiplegic

movement disorder, treatment of

MRI

MRI, abnormal

MRI, diffusion weighted

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic testing

neuronal cell death

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuroprotective agents

nonsteroidal anti-inflammatory drug

obsessive-compulsive disorder

octreotide

oculogyric crisis

olanzapine

osmotic demyelination syndrome

Parkinson disease, drug induced

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, treatment of

Parkinson disease, young onset

Parkinsonism syndrome

Parkinsonism-dementia complex

pathologic gambling

pathology

patient information and support

pituitary, adenoma, giant

pituitary, microadenoma

practice guidelines

pramipexole

pregnancy, neurologic complications in

prevention of neurologic disorders

psychiatric problems in neurologic disorders

psychosis

psychotic behavior

radiation necrosis

radiation therapy, CNS treatment and complications with

recurrent

renal failure

reserpine and reserpine like drugs

reserpine treatment in movement disorder

review article

rigidity

risk factors

sensorineural hearing loss

serotonin agonist

sinemet

single photon emission computed tomography

skin, lesions in neurologic disorders

sleep apnea

smell

sodium-glucoe cotransporter-2 inhibitors

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

sumatriptan

sweating

symmetric brain lesions

synucleinopathy

tardive akathisia

tardive dyskinesia

tardive dyskinesia, treatment of

tardive dystonia

tardive pain syndrome

tension headache

tetrabenazine

tetracycline

thalamus, lesion of-bilateral

thiothixene

tic

tic, chronic multiple

tic, classification of

treatment of neurologic disorder

Showing articles 0 to 50 of 3817 Next >>

SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
Neurol 103:e209805, Kim,H.K.,et al, 2024

Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024

Risk of First Ischaemic Stroke and Use of Antidopaminergic Antiemetics: Nationwide Case-Time-Control Study
BMJ 376:e061921, Benard-Laribiere, A.,et al, 2022

Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011

Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010

Parkinsonism in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Neurol 73:401-403, Tisch,S. &Brew,B., 2009

Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008

Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008

Individual Dopaminergic Neurons Show Raised Iron Levels in Parkinson Disease
Neurol 68:1820-1825, Oakley,A.E.,et al, 2007

A Trial of Metoclopramide vs Sumatriptan for the Emergency Department Treatment of Migraines
Neurol 64:463-468, Friedman, B.W., et al, 2005

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005

Parenteral Metoclopramide for Acute Migraine: Meta-Analysis of Randomised Controlled Trials
BMJ 329:1369-1372, Colman,I.,et al, 2004

[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003

Apoptosis and Caspases in Neurodegenerative Diseases
NEJM 348:1365-1375, Friedlander,R.M., 2003

Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001

Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999

Migraine in Pregnancy
Neurol 53:S26-S28, Aube,M., 1999

Tardive Dyskinesia:Diagnosis, Pathogenesis, and Management
The Neurologist 4:180-187, Trugman,J.M., 1998

Olanzapine Can Worsen Parkinsonism
Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 50:1195-1196, Wolters,E.C.,et al, 1998

Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995

The Effect of Comb Oral Lysine Acetylsalicylate & Metoclopramide Compared w/Oral Sumatriptan for Migraine
Lancet 346:923-926, Tfelt-Hansen,P.,et al, 1995

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994

Oral and Genital Tardive Pain Syndromes
Neurol 44:2115-2119, Ford,B.,et al, 1994

Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993

The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Int Med 153:1469-1475, Ganzini,L.,et al, 1993

Treatment of Parkinson's Disease
NEJM 329:1021-1027, Calne,D.B., 1993

Emergency Treatment of Headache
Neurol 42 (Suppl 2) :43-44992., Rapoport,A.M.&Silberstein,S.D., 1992

Tardive Dyskinesia Associated with Use of Metoclopramide in a Child
J Pediatr 121:983-985, Putnam,P.E.,et al, 1992

Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992

Acromegaly
NEJM 322:966-977, Melmed,S., 1990

Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989

Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989

Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989

Dopamine Agonists, In Parkinson's Disease and Movement Disorders
Urban & Schwarzenberg, Balt, p. 104., Jankovic,J.&Tolosa,E., 1988

Acute Upper Airway Obstruction Due to Supraglottic Dystonia Induced by a Neuroleptic
BMJ 297:964-965, Newton-John,H., 1988

Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987

Treatment of Gilles de la Tourette's Syndrome:Experience in a Predominantly Adult Population
Neurol 37:1828-1833, Mesulam,M.M.&Peterson,R.C., 1987

Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987

Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987

Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987

Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Int Med 147:1495-1497, Friedman,L.S.,et al, 1987

Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986

Tardive Dyskinesia Associated with High-Dose Intravenous Metoclopramide
NEJM 315:518-519, Breitbart,W., 1986

Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985

Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985

Metoclopramide & Tardive Dyskinesia in the Elderly
BMJ 289:397-398, Orme,M.L., 1984

Showing articles 0 to 50 of 3817 Next >>